Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2020-07-29 Director's Dealing
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. It details the share transactions (specifically a sale of shares) by an executive (Baek Seong-uk) of Yuyu Pharma. This type of filing, which reports personal share transactions by company insiders, is classified as 'Director's Dealing' (DIRS).
2020-07-29 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Yuyu Pharma, covering the period from January 1, 2020, to March 31, 2020. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document tracks changes in share ownership by major shareholders (often referred to as the '5% rule' filing). It details the reporting entity, special relations, shareholding ratios, and reasons for changes (such as collateral contract renewals). This fits the 'Major Shareholding Notification' category.
2020-05-11 Korean
최대주주등소유주식변동신고서(최대주주변경시)
Director's Dealing Classification · 98% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific share transfers (gifts/donations) between major shareholders and executives, resulting in a change in the major shareholder status. This type of filing is a standard regulatory disclosure regarding insider share ownership and major shareholder status changes, which falls under the 'Director's Dealing' (DIRS) category as it reports personal share transactions by company directors and major shareholders.
2020-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a director (Yoo Seung-pil) of Yuyu Pharma. This type of filing is a standard regulatory disclosure for insider transactions and ownership changes, which falls under the 'Director's Dealing' category.
2020-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and the Korea Exchange. This type of filing is a standard regulatory requirement for company insiders (directors/executives) to disclose changes in their personal shareholdings. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2020-04-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.